Literature DB >> 8288452

Internal cardioverter defibrillator device discharge: experiences of patients and family members.

S B Dunbar1, C D Warner, J A Purcell.   

Abstract

PURPOSE: The purpose of the study was to describe sensations, symptoms, and experiences of internal cardioverter defibrillator (ICD) activations from the perspective of patients and a member of their family.
METHODS: A prospective, descriptive study with qualitative and quantitative measures was used. Patients with an ICD returned a device activation form within 24 hours after receiving a shock and both patient and family members participated in interviews at 1, 3, and 6 months after ICD implantation. SAMPLE: Twenty-two patients with ICD (two women, 20 men) between the ages of 24 to 72 years (mean 56.5 years) and one family member per patient participated. Family members ranged in age from 43 to 67 years (mean 52.6 years) and were primarily spouses.
RESULTS: The most distressing aspects of receiving a shock were lack of warning, multiple shocks, and progressively increased sensations with multiple shocks. Mean shock intensity was ranked 5.44 on visual analog scale with a range of 0 to 10. The most frequently reported symptoms and sensations were generalized nervousness and terror/fear. Dizziness, general weakness, nausea and vomiting, palpitations, and chest soreness were also noted. IMPLICATIONS: Nursing interventions related to education of patients with an ICD and their families can incorporate knowledge of these experiences to facilitate anticipatory guidance and strengthen preparation of both the patient and family member for ICD device discharge. Further research as device technology evolves is warranted.

Entities:  

Mesh:

Year:  1993        PMID: 8288452

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  12 in total

Review 1.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

2.  Aerobic Fitness and Risk of Ventricular Arrhythmia Following Physical Exertion.

Authors:  Harpreet S Chahal; Elizabeth Mostofsky; Murray A Mittleman; Neville Suskin; Mark Speechley; Allan C Skanes; Peter Leong-Sit; Jaimie Manlucu; Raymond Yee; George J Klein; Lorne J Gula
Journal:  Can J Cardiol       Date:  2015-12-28       Impact factor: 5.223

3.  Patient expectations from implantable defibrillators to prevent death in heart failure.

Authors:  Garrick C Stewart; Joanne R Weintraub; Parakash P Pratibhu; Marc J Semigran; Janice M Camuso; Kimberly Brooks; Sui W Tsang; Mary Susan Anello; Viviane T Nguyen; Eldrin F Lewis; Anju Nohria; Akshay S Desai; Michael M Givertz; Lynne W Stevenson
Journal:  J Card Fail       Date:  2009-11-04       Impact factor: 5.712

4.  How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?

Authors:  F Duru; S Büchi; R Klaghofer; H Mattmann; T Sensky; C Buddeberg; R Candinas
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 5.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

6.  Cardiac ablation catheter guidance by means of a single equivalent moving dipole inverse algorithm.

Authors:  Kichang Lee; Wener Lv; Evgeny Ter-Ovanesyan; Maya E Barley; Graham E Voysey; Anna M Galea; Gordon B Hirschman; Kristen Leroy; Robert P Marini; Conor Barrett; Antonis A Armoundas; Richard J Cohen
Journal:  Pacing Clin Electrophysiol       Date:  2013-02-28       Impact factor: 1.976

7.  Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II.

Authors:  Katia Noyes; Ethan Corona; Peter Veazie; Andrew W Dick; Hongwei Zhao; Arthur J Moss
Journal:  Am J Cardiovasc Drugs       Date:  2009       Impact factor: 3.571

8.  Predictors of implantable cardioverter defibrillator shocks during the first year.

Authors:  Cynthia M Dougherty; Jim Hunziker
Journal:  J Cardiovasc Nurs       Date:  2009 Jan-Feb       Impact factor: 2.083

9.  Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients.

Authors:  Sandra B Dunbar; Jonathan J Langberg; Carolyn M Reilly; Bindu Viswanathan; Frances McCarty; Steven D Culler; Marian C O'Brien; William S Weintraub
Journal:  Pacing Clin Electrophysiol       Date:  2009-10       Impact factor: 1.976

10.  Supraventricular tachycardia and the struggle to be believed.

Authors:  Kathryn A Wood; Carolyn L Wiener; Jeanie Kayser-Jones
Journal:  Eur J Cardiovasc Nurs       Date:  2007-04-03       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.